Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114857) titled 'Research on Risk Assessment of Malignant Transformation for Non-hypervascular Hepatobiliary-phase Hypointense Nodules in the Liver Based on EOB-MRI' on Dec. 18, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Affiliated Hospital of Qingdao University
Condition:
Hepatocellular Carcinoma
Intervention:
Training and validation sets:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Training and validation sets:156;Test group:47;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...